USE OF HIGH-DOSE METHOTREXATE (HD-MTX) IN LEPTOMENINGEAL METASTASIS (LM) IN PATIENTS WITH BREAST CANCER

被引：0
|
作者：
Tsyvkin, Elina [1 ]
Rauschkolb, Paula [2 ]
Pentsova, Elena [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Intermt Med Grp, Murray, UT USA
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [31] PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
    Schaff, Lauren
    Lobbous, Mina
    Bozza, Alexis
    Carlow, Dean
    Nabors, Louis
    Grommes, Christian
    NEURO-ONCOLOGY, 2020, 22 : 25 - 26
  • [32] RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE (HD-MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (HD-ARAC) FOR PATIENTS WITH PRIMARY CNS LYMPHOMA (IELSG # 20 TRIAL): TOLERABILITY, ACTIVITY AND SURVIVAL ANALYSES
    Ferreri, Andres J. M.
    Reni, Michele
    Foppoli, Marco
    Martelli, Maurizio
    Siakantaris, Marina
    Frezzato, Maurizio
    Cabras, Maria Giuseppina
    Fabbri, Alberto
    Corazzelli, Gaetano
    Ilariucci, Fiorella
    Rossi, Giuseppe
    Soffietti, Riccardo
    Stelitano, Caterina
    Vallisa, Daniele
    Zaja, Francesco
    Gelemur, Marta
    Aondio, Gian Marco
    Avvisati, Giuseppe
    Balzarotti, Monica
    Brandes, Alba
    Costa, Maria Joao
    Gomez, Henry
    Guarini, Attilio
    Pinotti, Graziella
    Rigacci, Luigi
    Uhlmann, Catrina
    Ponzoni, Maurilio
    Zucca, Emanuele
    Caligaris-Cappio, Federico
    Cavalli, Franco
    ANNALS OF ONCOLOGY, 2009, 20
  • [33] Randomized phase II trial on primary chemotherapy with high-dose methotrexate (HD-MTX) alone or associated with high-dose cytarabine (HD-araC) for patients with primary CNS lymphoma (IELSG #20 Trial): Tolerability, activity, and survival analyses
    Ferreri, A. J.
    Reni, M.
    Martelli, M.
    Pangalis, G.
    Frezzato, M.
    Cabras, G.
    Fabbri, A.
    Corazzelli, G.
    Zucca, E.
    Cavalli, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: Is intrathecal chemotherapy necessary?
    Glantz, MJ
    Cole, BF
    Recht, L
    Akerley, W
    Mills, P
    Saris, S
    Hochberg, F
    Calabresi, P
    Egorin, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1561 - 1567
  • [35] TREATMENT OF ADVANCED COLORECTAL-CARCINOMA WITH HIGH-DOSE METHOTREXATE (HD-MTX) GIVEN ALONE AND IN COMBINATION WITH 5-FLUOROURACIL (5-FU)
    ISACOFF, WH
    TISMAN, G
    BLOCK, JB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 381 - 381
  • [36] HIGH DOSE-METOTREXATE (HD-MTX) TOXICITY IN A PEDIATRIC COHORT WITH LAL: CHARACTERISTICS AND CARBOXIPEPTIDASE USE
    Garcia, I. G.
    Alvarez, E.
    Alvarez, Ch
    Diaz, L.
    Tong, H. Y.
    Hernandez, R.
    Borobia, A. M.
    Ramirez, E.
    Frias, J.
    Carcas, A. J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 31 - 31
  • [37] COMPARATIVE OUTCOME OF CHILDHOOD OSTEOSARCOMA TREATED WITH 2 CONSECUTIVE PROTOCOLS: HIGHLIGHTING THE EFFECTIVENESS OF HIGH-DOSE METHOTREXATE (HD-MTX) IN A SINGLE INSTITUTE'S EXPERIENCE
    Worawut, C.
    Pakakasama, S.
    Hongeng, S.
    Hutsadol, S.
    Sirachainan, N.
    Chuansumrit, A.
    Anurathapan, U.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 88 - 88
  • [38] Evaluation of simplified preanalytical Conditions for the Determination of Methotrexate (MTX) and MTX Metabolites by Liquid Chromatography / Tandem Mass Spectrometry (LC-MS/MS) in Blood Samples from Patients after High-dose MTX Therapy (HD-MTX) and Glucarpidase Treatment
    Knoernschild, F.
    Merz, I
    Jahic, A.
    Kiessling, P.
    Kappert, K.
    Keller, U.
    Schwartz, S.
    Liebig, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 162 - 162
  • [39] HIGH-DOSE METHOTREXATE WITH CITROVORUM FACTOR RESCUE (HD-MTX) ALTERNATING WITH COMBINATION CHEMOTHERAPY (M-CAV-CME) IN SMALL CELL LUNG-CANCER (SC LUNG CA)
    SKARIN, AT
    GREENE, H
    CANELLOS, GP
    TAKVORIAN, R
    FREI, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 328 - 328
  • [40] Orelabrutinib, Rituximab, and High-Dose Methotrexate (HD-MTX) in Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL): A Retrospective Analysis on Efficacy, Safety, and Biomarker
    Zhao, Shihua
    Liu, Yao
    Zhu, Zunmin
    He, Jianxia
    Liu, Lihong
    Wang, Xiaobo
    Zhao, Yuxia
    Hu, Chongling
    Yuan, Xiaoli
    Bai, Sijun
    Geng, Ye
    Huang, Wenrong
    BLOOD, 2022, 140 : 1338 - 1339
12345